Загрузка...
Recent Developments, Utilization, and Spending Trends for Pompe Disease Therapies
BACKGROUND: Pompe disease is a rare condition, with an incidence rate estimated to be between 1 in 40,000 and 1 in 300,000 live births worldwide. For an infant who contracts the disease, which is an inherited metabolic myopathy caused by deficiency of the acid alpha-glucosidase (GAA) enzyme in lysos...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Engage Healthcare Communications, LLC
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4046468/ https://ncbi.nlm.nih.gov/pubmed/24991319 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|